Consilient Health
Consilient Health is a privately held, profitable Dublin-based pharmaceutical company that in-licenses and commercializes niche, differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets through long-term partnerships with biotech and pharma manufacturers.
- Company typePrivate
- Founded2005
- HeadquartersDublin, Ireland
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Consilient Health does
Consilient Health Limited is a Dublin-headquartered, privately held pharmaceutical company founded in 2005 that commercializes niche and differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets (Sweden, Norway, Denmark, Finland), with partnership-driven extensions into Benelux and Spain. The company runs three regional platforms — consilienthealth.co.uk, consilienthealth.ie, and consilienthealth.nu — and pursues a licensing/royalty revenue model anchored by long-term strategic partnerships with both small biotech firms and large publicly listed manufacturers. Its offering spans the full in-country commercialization stack: regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales, performed by in-house country-led teams in each operating region. The technology underpinning the business is a pharmaceutical commercialization and distribution platform rather than a software product, with value created through product registration, market access, and direct sales execution rather than proprietary code.
Consilient Health is profitable and independent, with majority ownership held by Non-Executive Chairman Shane Reihill's family investment vehicle. Leadership is headed by CEO Luke Crosbie (appointed May 2022 after serving as Executive Vice Chairman since 2005), with COO Dr Roger Wu, CMO Dr Anne Fairey, and Finance Director John Fagan, alongside a non-executive board featuring senior industry figures including ex-Boehringer Ingelheim UK/Ireland MD John Dixon and ex-Grunenthal/ArjoHuntleigh CEO Harald Stock. In February 2023 the company divested its OC Distributors subsidiary (Ireland-based, women's healthcare) to Gedeon Richter plc for GBP 32.5 million, signaling portfolio refocusing on its differentiated-prescription core; the same period saw a deliberate scaling of the Business Development function with multiple senior hires in 2023 and 2024 to expand the in-licensing pipeline. The company has no disclosed external funding, no parent company, and no public listing.
Consilient Health firmographics
Firmographics- Name
- Consilient Health
- Legal name
- Consilient Health Limited
- Website
- https://consilienthealth.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Consilient Health is a privately held, profitable Dublin-based pharmaceutical company that in-licenses and commercializes niche, differentiated prescription medicines across multiple therapeutic areas in the UK, Ireland, and Nordic markets through long-term partnerships with biotech and pharma manufacturers.
- Ownership category
- akta.pro rank
Consilient Health industry classification
Industry- Product category
- Pharmaceutical Commercialization
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Consilient Health is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices3 records
Markets served
Consilient Health business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Pharmaceutical Product Commercialization: Consilient Health generates revenue by commercializing prescription healthcare products through strategic partnerships with pharmaceutical companies. The company focuses on products that address unmet clinical needs, managing market access, marketing, sales, and distribution in the UK and European markets.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels3 records
Consilient Health product offering
Product offeringCore offering
Consilient Health commercializes niche and differentiated prescription pharmaceutical products across multiple therapeutic areas in the UK and European markets through strategic partnerships with pharmaceutical developers and manufacturers. The company evaluates products and focuses on those with potential to address clear unmet clinical needs, managing market access, marketing, sales, and distribution on behalf of partners. Its operations span regulatory affairs, supply chain, distribution, medical affairs, marketing, and sales across UK, Ireland, and the Nordics.
Product overview
Consilient Health is a pharmaceutical company that commercializes differentiated and niche prescription healthcare products across multiple therapeutic areas. The company operates through regional platforms for Ireland (consilienthealth.ie), the United Kingdom (consilienthealth.co.uk), and the Nordic region (consilienthealth.nu), offering prescription medicines through partnerships with pharmaceutical developers and manufacturers. The company focuses on products addressing unmet clinical needs, with capabilities spanning regulatory affairs, market access, supply chain management, distribution, medical affairs, marketing, and sales. Specific product names are available on the regional websites rather than the main corporate site.
Differentiator
Problem solved
Functional benefit
Products and services
- Prescription Pharmaceutical Commercialization (UK) Licensing and commercialization of niche and differentiated prescription pharmaceutical products in the UK market through direct sales and marketing operations, serving pharmaceutical companies seeking market access without their own UK infrastructure.
- Prescription Pharmaceutical Commercialization (Ireland) Licensing and commercialization of prescription pharmaceutical products across Ireland and Malta, established with a dedicated country team and offering primary and secondary care market access.
- Prescription Pharmaceutical Commercialization (Nordics) Licensing and commercialization of prescription pharmaceutical products across Sweden, Norway, Denmark, and Finland, with a regional headquarters in Uppsala, Sweden, and partnerships extending into Benelux and Spain.
- Generic Pharmaceuticals (UK) UK generic pharmaceuticals business and trade management servicing large retail chains and national wholesalers, also managing international export opportunities.
- Women's Healthcare Products (OC Distributors Ltd) Previously marketed and distributed women's healthcare products in Ireland via wholly-owned subsidiary OC Distributors Ltd; in February 2023 the subsidiary was sold to Gedeon Richter plc.
Companies that use Consilient Health
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Consilient Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Consilient Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered major and core.
- Gedeon Richter plcmajorConsilient Health shareholders sold 100% control of OC Distributors Ltd, an Ireland-based company holding marketing and distribution rights for women's healthcare products, to Gedeon Richter plc. Transaction valued at GBP 32.5 million.
- Sustainable Medicines Partnership (SMP)coreConsilient Health joined the Sustainable Medicines Partnership as a Founding Collaborator. SMP is a not-for-profit, private-public, multi-stakeholder collaborative aimed at stopping the avoidable waste of medicines and medicines packaging. Through a four-year programme, SMP aims to build science-based, scalable, sustainable solutions to reduce medicine waste and healthcare emissions globally.
- Pharmaceutical PartnerscoreConsilient Health has established long-term, mutually beneficial partnerships with pharmaceutical developers and manufacturers spanning from small innovative biotech firms to large publicly listed companies. The company seeks partnerships with companies that share high ethical standards, are performance-driven, and committed to long-term collaborations.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Consilient Health competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Consilient Health social profiles
Digital presenceConsilient Health compliance and trust
Trust signalCompliance5 records
Consilient Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Consilient Health leadership team
Management profileNumber of profiles
Profiles17 records
Consilient Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
Consilient Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Consilient Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Consilient Health
What does Consilient Health do?
Consilient Health commercializes niche and differentiated prescription pharmaceutical products across multiple therapeutic areas in the UK and European markets through strategic partnerships with pharmaceutical developers and manufacturers. The company evaluates products and focuses on those with potential to address clear unmet clinical needs, managing market access, marketing, sales, and distribution on behalf of partners. Its operations span regulatory affairs, supply chain, distribution, medical affairs, marketing, and sales across UK, Ireland, and the Nordics.
Is Consilient Health a public or private company?
Consilient Health is a private company. It is classified as family owned and is currently operating.
When was Consilient Health founded?
Consilient Health was founded in 2005. It employs 51 to 100 people.
Where is Consilient Health based?
Consilient Health is headquartered in Dublin, Ireland, in the Europe region.
How does Consilient Health make money?
One revenue line is on record: pharmaceutical Product Commercialization.
Does Consilient Health have an API?
No public API is recorded for Consilient Health.
What industry is Consilient Health in?
Consilient Health's product category is Pharmaceutical Commercialization. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 42421 and its SIC code is 5122.